|
Funding
Alydar received seed funding from Medison Biotech, the investment arm of the Medison Group, which includes Medison Pharma, an Israel-based leading pharmaceutical marketing company.
Financing Plans
Alydar seeks Series A investment to expand its research, development, and business activities aimed at developing new infochemical-derived pharmaceuticals and commercializing them through alliances with pharmaceutical and biotechnology companies.
|
 |
